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Abstract
Background: Nontypeable Haemophilus influenzae (NTHi) is one of the most common Gram-negative pathogens in
otitis media and exacerbation of chronic obstructive pulmonary disease. NTHi has been reported to invade
bronchial epithelial cells. This penetration enables NTHi to evade the host immune system and antibiotics, and it
seems to be related to the intractable features of these diseases. However, the precise mechanism of the invasion
has been unknown. We hypothesized that protein-E, an outer membrane protein of NTHi, plays a role in this
penetration into bronchial epithelial cells.
Results: We utilized two NTHi strains. NTHi efficiently attached to plate-bound vitronectin (254–309 / field at 1,000×
magnification) and this attachment was blocked by pretreatment with protein-E peptide (PE84–108). The blockade of
adhesion was dependent on the concentration of PE84–108. NTHi strains invaded bronchial epithelial cells and the
intracellular bacteria were localized in early endosomes. Furthermore, intracellular invasion of NTHi was also blocked by
PE84–108, but not by Arg-Gly-Asp (RGD) peptide. Pretreatment with PE84–108 significantly prevented cells from being
invaded by both NTHi strains, which was confirmed by fluorescent microscope observation. In addition, pretreatment
with PE84–108 significantly reduced percentages of CFU after gentamicin treatment of cells per input CFU.
Conclusions: These results suggest that NTHi does not directly bind to the cell surface, but binds to host vitronectin
that is bound to the cell surface, via bacterial protein-E. Bacterial protein-E and host vitronectin play a role in the
attachment to bronchial epithelial cells and is also involved in the subsequent intracellular invasion of NTHi. A novel
vaccine or treatment strategy targeting the protein-E-vitronectin axis may prevent respiratory intracellular infection of
NTHi and may lead to better clinical outcomes.
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Background
Haemophilus influenzae (H. influenzae) is a Gram-
negative bacterium and is one of the most prevalent
pathogens worldwide. Some H. influenzae strains have a
polysaccharide capsule and they are divided into six se-
rotypes (a-f ), termed typeable H. influenzae. The other
strains do not possess a capsule, and they are termed
nontypeable H.influenzae (NTHi). NTHi is a major
pathogen of mucosal infections such as otitis media and
exacerbation of chronic obstructive pulmonary disease
(COPD) [1, 2]. Substantial numbers of COPD patients
are colonized by NTHi in their lower airways, and this
type of bacteria frequently causes chronic bronchitis and
acute exacerbation of COPD [3].
NTHi can invade host bronchial epithelial cells, and
this invasion enables NTHi to escape from host immune
system [4, 5]. Intracellular NTHi is able to evade high
concentration of antibiotics and becomes clinically
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intractable [6, 7]. Therefore, preventing NTHi from in-
vading epithelial cells is crucially important for the
prophylaxis and treatment of diseases mentioned above.
However, the exact mechanism by which NTHi breaks
into bronchial epithelial cells has been unknown.
To penetrate into bronchial epithelial cells, adherence
of NTHi to these cells is essential. Previous studies re-
ported the significance of adhesion molecules for the
direct attachment of NTHi to epithelial cells [8, 9–11].
Some of these adhesion molecules on NTHi such as
high-molecular-weight proteins (HMW1 and 2) possess
Arg-Gly-Asp (RGD) sequence [12], and this RGD se-
quence can bind to integrin-receptors on epithelial cell
surface [11].
In addition, vitronectin, which is in plasma and extra-
cellular matrix, also binds to NTHi and is related with
its adhesion to cells [13]. A recent report showed that
protein-E (gene name pe, HI 0178 in Rd KW20 strain,
NTHI 0267 in 86-028NP strain), a NTHi outer mem-
brane protein binds vitronectin and is related to NTHi
serum resistance [14]. Vitronectin possesses three
heparin-binding domains (HBDs) [15] and the C-
terminal HBD-3 corresponds to a protein E binding re-
gion [16]. Vitronectin also has RGD sequence which
binds to integrin receptors on epithelial cell surface [15].
However, the role of protein-E and vitronectin in the
intracellular invasion of NTHi has not been fully
elucidated.
In the present study, we demonstrated that intracellu-
lar invasion of NTHi into bronchial epithelial cells is
dependent on protein-E via its binding with vitronectin.
To our knowledge, this is the first report to show that
protein-E not only plays a role in the attachment to epi-
thelial cells but also is involved in the subsequent intra-
cellular invasion of NTHi. The protein-E-vitronectin
axis may become a novel therapeutic and vaccine target
for NTHi infection.
Methods
Bacterial strains and cell culture
Two strains of NTHi were used in this study. One was
NTHi clinical isolate HUSM 0481, which was cultured
from the sputum of a patient with community-acquired
pneumonia at Hamamatsu University Hospital in Hama-
matsu, Japan. The sample was taken as part of standard
care. The other was a commercially available NTHi
strain ATCC 19418 (American Type Culture Collection
(ATCC), Manassas, VA). NTHi was precultured in brain
heart infusion (BHI) liquid broth supplemented with
NAD and hemin (both at 1 μg/ml) and cultured over-
night on chocolate agar plates at 37 °C.
Escherichia coli (E. coli, strain Le392) and Listeria
monocytogenes (L. monocytogenes, strain 10403 s) were
precultured in BHI.
BEAS-2B cells (ATCC), a human bronchial epithelial
cell line, were cultured on glass-bottomed dishes in
LHC-8 medium without gentamicin (Life technologies/
Gibco, Carlsbad, CA) containing 500 ng/ml of epineph-
rine (Sigma-Aldrich, St. Louis, MO) and 0.1 ng/ml of
retinoic acid (Sigma-Aldrich).
Infection with bacteria and evaluation of their
penetration into BEAS-2B cells
Confluent BEAS-2B cells on glass-bottomed dishes were
infected with several types of bacteria at a multiplicity of
infection (MOI) of 100 for 2 hours at 37 °C with 5 % CO2.
After killing any extracellular bacteria with a 2-hour treat-
ment of 100 μg/ml gentamicin (Sigma-Aldrich) and wash-
ing 3 times, epithelial cells and bacteria were stained with
the mixture of 1.5 μl of 3.34 mM SYTO 9 and 1.5 μl of
20 mM propidium iodide per 2 ml of medium (LIVE/
DEAD® BacLight bacterial viability kit, Invitrogen/Molecu-
lar Probes, Eugene, OR) for 15 minutes according to the
manufacturer’s instructions, and then stained with 10 μg/
ml of Hoechst 33342 (Hoechst, Invitrogen/Molecular
Probes) for 30 minutes to evaluate the invaded cells. The
numbers of cells with one or more intracellular bacteria
were counted with a fluorescent microscope (BZ-9000;
Keyence, Osaka, Japan). One hundred cells were counted
three times at different sites, at a magnification of 1,000×,
and the percentage of invaded cells was calculated. For the
evaluation of viable intracellular bacteria, cells were lysed
with distilled water, after killing of extracellular bacteria
with gentamicin and washing 3 times as described above,
and the bacteria were cultured on chocolate-agar plates
overnight at 37 °C. Then, the percentage of colony num-
ber after gentamicin treatment per input bacterial number
was calculated.
Immunofluorescent staining and evaluation of NTHi
localization in BEAS-2B cells
After infection with NTHi and treatment with gentami-
cin to kill the extracellular bacteria, cells were fixed with
4 % paraformaldehyde phosphate (4 % PFA, Wako,
Osaka, Japan) for 15 minutes at room temperature.
Specimens were incubated with 1 % BSA in PBS for
30 minutes and washed with PBS three times. Early
endosomes were stained with goat anti-human EEA1
(N-19) antibody (Santa Cruz Biotechnology, Dallas, TX).
Late endosomes were stained with mouse monoclonal
anti-human LAMP-1 (H4A3) antibody (Santa Cruz Bio-
technology). As for the staining of acidic endosomes,
after staining of viable bacteria with LIVE/DEAD® with-
out 4 % PFA, acidic endosomes were stained with Lyso-
Tracker® Red (Molecular Probes/Life Technologies,
Carlsbad, CA). Nuclei were stained with Hoechst. After
staining, micrographs were taken with a fluorescent
microscope (BZ-9000).
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Adhesion of NTHi to immobilized vitronectin
Vitronectin from human plasma (0.1 μg/cm2; Sigma-
Aldrich) was incubated on glass-bottomed dishes at 37 °
C for 2 hours. Bovine serum albumin (BSA; 0.1 μg/cm2;
Sigma-Aldrich), as a negative control, was also incubated
on glass-bottomed dishes. In some experiments,
1,000 μg/ml of heparin (Sigma-Aldrich) or 100 μg/ml of
protein-E peptide (PE84–108; MBL, Nagoya, Japan) was
incubated with plate-bound vitronectin for 60 minutes
before NTHi incubation. PE84–108 peptide was synthe-
sized based on the predicted amino acid sequence from
HI 0178 [17]. NTHi was incubated on the dishes for
30 minutes, and the dishes were washed with PBS three
times. Attached NTHi were stained with LIVE/DEAD®
for 15 minutes, and the number of bacteria was counted
with a fluorescent microscope (BZ-9000) at a magnifica-
tion of 1,000 × .
Detection of vitronectin on BEAS-2B Cells
Confluent BEAS-2B cells on glass-bottomed dishes were
fixed with 4 % paraformaldehyde phosphate for 15 mi-
nutes at room temperature. Cells were incubated with
1 % BSA in PBS for 30 minutes. After washing with PBS,
5.0 μg/ml of monoclonal antibody to human vitronectin
(Takara, Otsu, Japan) was added and incubated for
60 minutes. After washing, 2 μg/ml of goat anti-mouse
IgG H&L-Alexa flour®568 (Abcam, Cambridge, UK) was
also incubated for 60 minutes. Nuclei were stained with
10 μg/ml of Hoechst for 30 minutes. The expression of
vitronectin was evaluated with a fluorescent microscope
(BZ-9000).
Blocking of NTHi penetration into BEAS-2B cells
Before infection with NTHi, BEAS-2B cells were pre-
treated with 1,000 μg/ml of heparin for 30 minutes,
10 μM of Arg-Gly-Asp (RGD) peptide for 60 minutes, or
100 μg/ml of PE84–108 peptide for 60 minutes. Subse-
quently, the cells were infected with NTHi strains for
2 hours. After treatment with gentamicin for 2 hours to
kill extracellular NTHi, the amount of invaded cells and
the amount of intracellular NTHi were evaluated.
Statistical analysis
Data from multiple experiments were expressed as the
mean ± standard error of the mean (SEM). Data were
analyzed using a one-way ANOVA with Tukey’s post-
hoc test for the comparison of three or more groups, or
analyzed using a two-sided unpaired t test for the com-
parison of two groups. When one of the values was less
than 5, data were analyzed using Fisher’s exact probabil-
ity test. Statistical analyses were performed using SPSS
Statistics version 22 (Japan IBM, Tokyo, Japan). A p
value of < 0.05 was considered statistically significant in
all tests.
Results
NTHi penetrates into bronchial epithelial cells
Two strains of NTHi were used in this study: a commer-
cially available NTHi strain ATCC 19418 and a clinical
isolate HUSM 0481. To confirm whether NTHi can in-
vade bronchial epithelial cells, BEAS-2B cells were in-
fected with NTHi for 2 hours. BEAS-2B cells were also
infected for 2 hours with E. coli as a negative control or
L. monocytogenes as a positive control. After killing
extracellular bacteria with gentamicin, epithelial cells
and bacteria were stained with LIVE/DEAD® and
Hoechst and evaluated with a fluorescent microscope.
Viable bacteria and cells are stained green, and dead
bacteria and cells are stained red. Fluorescent micro-
graphs showed that viable L. monocytogenes and NTHi
strain ATCC19418 penetrate into BEAS-2B cells (repre-
sentative images shown in Fig. 1a). The percentages of
cells invaded by bacteria are summarized in Fig. 1b. The
percentage of cells invaded by NTHi strain ATCC 19418
was 26.4 ± 4.1 % (mean ± SEM) and that by the HUSM
0481 strain was 24.0 ± 2.8 %. There were significant dif-
ferences between the percentage of cells invaded by E.
coli and that by both NTHi strains (ATCC 19418: p <
0.001 and HUSM 0481: p < 0.001 with Fisher’s exact
probability test).
Next, after killing extracellular bacteria with gentami-
cin, cells were lysed and the bacteria were cultured over-
night. Then, the number of bacterial colonies was
counted. The percentage of colony number after genta-
micin treatment per input bacterial number is shown in
Fig. 1c. Those were 5.17 ± 1.11 % in ATCC 19418 and
5.97 ± 2.66 % in HUSM 0481. There were also significant
differences between the percentage of intracellular bac-
teria in E. coli and that in both NTHi strains (ATCC
19418: p = 0.036 and HUSM 0481: p = 0.048).
Localization of intracellular NTHi
The localization of NTHi in epithelial cells was con-
firmed with a fluorescent microscope. BEAS-2B cells
were infected with NTHi strain ATCC 19418 for 2 hours.
After killing extracellular bacteria with gentamicin, epi-
thelial cells and bacteria were stained with several fluor-
escent dyes. DNA of both intracellular bacteria and
BEAS-2B cells were stained blue with Hoechst. Fluores-
cent micrographs at 2,000× magnification showed that
intracellular NTHi (blue) localizes in early endosomes
stained with EEA-1 (red) (representative images shown
in Fig. 2a). However, the intracellular NTHi did not co-
localize with LAMP-1 (purple; Fig. 2b), which marks late
endosomes, or with acidic organelles that were marked
with LysoTracker® Red (red; Fig. 2c), indicating that
intracellular NTHi does not exist in late endosomes or
in acidic organelles. Another strain (HUSM 0481) was
also tested and similar results were obtained.
Ikeda et al. BMC Microbiology  (2015) 15:263 Page 3 of 11
NTHi binds to immobilized vitronectin and this
Interaction is blocked by heparin
Attachment to cells is important for bacterial invasion
into bronchial epithelial cells. Therefore, the capacity of
NTHi to bind to immobilized vitronectin was evaluated.
Human plasma vitronectin was bound to glass-bottomed
dishes. NTHi was incubated on the plate-bound vitro-
nectin with or without pretreatment of 1,000 μg/ml hep-
arin. Fluorescent micrographs showed that both NTHi
strains attached to plate-bound vitronectin in the ab-
sence of heparin, but that this attachment was blocked
in the presence of heparin (representative images shown
in Fig. 3a and b). A summary of the numbers of attached
NTHi per field at 1,000× magnification is shown in
Fig. 3c (ATCC 19418) and in Fig. 3d (HUSM 0481). The
number of ATCC 19418 bacteria adhered to plate-bound
vitronectin was 254 ± 28/field (mean ± SEM) and this
number was significantly reduced to 168 ± 16/field by
blocking with heparin (Fig. 3a and c, p < 0.001). The
number of HUSM 0481 bacteria adhered to plate-bound
vitronectin was 309 ± 18/field, and this number signifi-
cantly decreased to 160 ± 10/field by blocking with hep-
arin (Fig. 3b and d, p < 0.001).
BEAS-2B cells express vitronectin
We next examined whether BEAS-2B cells express vitro-
nectin. BEAS-2B cells were stained with mouse anti-
human vitronectin-antibody (primary antibody) and then
with goat anti-mouse IgG antibody (secondary antibody,
yellow). Nuclei were stained with Hoechst (blue). Repre-
sentative fluorescent micrographs at 1,000× magnification

































































Fig. 1 NTHi penetration of bronchial epithelial cells. BEAS-2B cells were infected with one of two NTHi strains (ATCC 19418 or HUSM 0481), E. coli
(a negative control), or L. monocytogenes (a positive control) for 2 hours. After killing extracellular bacteria with gentamicin, epithelial cells and
bacteria were stained with LIVE/DEAD® and Hoechst. a Representative fluorescence micrographs of L. monocytogenes, and NTHi strain ATCC
19418. White arrows show viable intracellular bacteria stained green. White bars represent 5 μm. Fluorescent micrographs were taken at 2,000×
magnification. b The percentages of epithelial cells invaded by bacteria. c After killing extracellular bacteria with gentamicin, cells were lysed and
the bacteria were cultured overnight. The number of colonies was counted and the percentages of CFU after gentamicin treatment per input
CFU were shown. Error bars represent SEM in three independent experiments that gave similar results. *p < 0.05 and **p < 0.01
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control, BEAS-2B cells were stained with secondary anti-
body alone (Additional file 1: Figure S1A). BEAS-2B cells
were clearly positive for vitronectin (Additional file 1:
Figure S1B). Further, there was no obvious difference in
expression of vitronectin before or after NTHi infection
(Additional file 1: Figure S1C).
Intracellular invasion of NTHi is blocked by heparin, but
not by RGD peptide
To determine whether intracellular invasion of NTHi is
blocked by either heparin or RGD peptide, BEAS-2B
cells were infected for 2 hours with one of the two NTHi
strains (ATCC 19418 or HUSM 0481), E. coli (a negative
control), or L. monocytogenes (a positive control) with or
without pretreatment with heparin or RGD peptide. The
percentage of BEAS-2B cells invaded by each type of
bacteria is shown in Fig. 4a. Pretreatment with heparin,
but not with RGD peptide, significantly decreased the
invasion of NTHi strains (Fig. 4a, ATCC 19418: p <
0.001 between NTHi and NTHi + heparin, HUSM 0481:
p < 0.012 between NTHi and NTHi + heparin). Pretreat-
ment with heparin, but not with RGD peptide, also sig-
nificantly reduced proportions of intracellular bacteria
(Fig. 4b, ATCC 19418: p = 0.016 between NTHi and
NTHi + heparin, HUSM 0481: p = 0.016 between NTHi
and NTHi + heparin).
Intracellular invasion of NTHi is blocked by heparin in a
dose-dependent manner
Next, we evaluated how different concentrations of hep-
arin affect the penetration of NTHi into bronchial epi-
thelial cells. BEAS-2B cells were pretreated with several
concentrations of heparin, and then these cells were in-
fected with one of the two NTHi strains for 2 hours.
The number of intracellular colonies significantly de-
creased as the heparin concentration increased in both
strains of NTHi (Additional file 2: Figure S2A, ATCC
19418: p = 0.018 between 0 and 1,000 μg/mL of heparin;
Additional file 2: Figure S2B, HUSM 0481: p = 0.01 be-
tween 0 and 1,000 μg/mL of heparin).
Adherence of NTHi to immobilized vitronectin is blocked
by protein-E peptide
To confirm whether bacterial protein-E is important for
the ability of NTHi to adhere to vitronectin, a blocking
experiment with protein-E peptide (PE84–108) was con-
ducted. NTHi (HUSM 0481) was incubated on the
plate-bound vitronectin with or without pretreatment
with PE84–108. Fluorescent micrographs showed that
NTHi attachment to plate-bound vitronectin was
blocked by pretreatment with 100 μg/ml of PE84–108
(representative images shown in Fig. 5a). The number of
bacteria attached to vitronectin per field at 1,000× mag-
nification in each NTHi strain is shown in Fig. 5b. This
number significantly decreased as the concentrations of
PE84–108 increased in both strains (ATCC 19418: p <
0.001 between 0 and 100 μg/ml of PE84–108, HUSM
0481: p < 0.001 between 0 and 100 μg/mL of PE84–108).
Intracellular invasion of NTHi is dependent on protein-E
To determine whether protein-E is essential for NTHi
penetration into bronchial epithelial cells, a blocking ex-
periment with protein-E peptide was conducted. BEAS-
2B cells were infected with one of the two NTHi strains
(ATCC 19418 or HUSM 0481) with or without pretreat-









Fig. 2 Localization of intracellular NTHi. BEAS-2B cells were infected
with NTHi strain ATCC 19418 for 2 hours. After killing extracellular
bacteria with gentamicin, epithelial cells and bacteria were stained
with several fluorescent dyes and Hoechst (blue). a Representative
fluorescent micrographs of intracellular NTHi (blue) and epithelial
cells stained with early endosomal marker (EEA-1, red). White arrows
show EEA-1-positive regions, and white arrowheads show NTHi. For
a detail of merged image, see a top-right inset. b Representative
fluorescence micrographs of intracellular NTHi (blue) and epithelial
cells stained with late endosomal marker (LAMP-1, purple). White
arrows show LAMP-1-positive regions, and white arrowheads show
NTHi. For a detail of merged image, see a top-right inset.
c Representative fluorescent micrographs of intracellular NTHi and
epithelial cells stained with LIVE/DEAD® (green) and cells were
stained with acidic lysosomal dye (LysoTracker® Red). White arrows
show LysoTracker® Red-positive acidic organelles, and white
arrowheads show NTHi. Fluorescent micrographs were taken at
2,000× magnification. White bars represent 5 μm. Another strain
(HUSM 0481) was also tested and similar results were obtained
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BEAS-2B cells invaded by each NTHi strain is shown in
Fig. 6a. Pretreatment with PE84–108 significantly reduced
the percentage of invaded cells by either strain of NTHi
(Fig. 6a, ATCC 19418: p < 0.001, HUSM 0481: p < 0.01).
In addition, pretreatment with PE84–108 significantly re-
duced the percentage of intracellular NTHi strains after
gentamicin treatment of infected BEAS-2B cells (Fig. 6b,
ATCC 19418: p = 0.049, HUSM 0481: p = 0.024).
Discussion
Although NTHi was originally thought to be an extracel-
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Fig. 3 NTHi binding of immobilized vitronectin in the absence or presence of heparin. Human plasma vitronectin was bound to glass-bottomed
dishes. NTHi was incubated on the plate-bound vitronectin for 30 minutes, and then the dishes were washed three times. In some experiments,
plate-bound vitronectin was pretreated with heparin before incubation with NTHi. NTHi was stained with LIVE/DEAD®. Live NTHi is stained green.
BSA was used as a negative control. Representative fluorescent micrographs show that both NTHi strains (ATCC 19418 (a) and HUSM 0481 (b))
attached to plate-bound vitronectin and that this attachment is blocked by heparin. White bars represent 10 μm. Summaries of the numbers of
attached NTHi (per field at 1,000× magnification) are shown in (c) for ATCC 19418 and (d) for HUSM 0481. Error bars represent SEM in three
independent experiments that gave similar results. **p < 0.01
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breaks into bronchial epithelial cells, probably to evade
the host immune system. This feature of NTHi assists
the bacteria in persisting and may contribute to the in-
tractability of COPD [6, 7]. Thus, it is important to clar-
ify the mechanisms of NTHi intracellular invasion for
the development of a novel strategy against NTHi infec-
tion. In this study, we demonstrated intracellular inva-
sion of NTHi into bronchial epithelial cells, and we
found that this invasion was able to be blocked by
protein-E peptide or heparin, but not by RGD peptide.
These results suggest that NTHi do not directly pene-
trate into bronchial epithelial cells but instead exploits
protein-E and vitronectin for invasion into bronchial
epithelial cells (Fig. 7). To our knowledge, this is the first
report that protein-E plays a key role in the intracellular
invasion of NTHi as well as in NTHi attachment to
bronchial epithelial cells.
Although there have been several studies reporting
possible mechanisms of NTHi adhesion to epithelial
cells, the mechanisms of the intracellular invasion
remained poorly understood. NTHi has several adhesion
molecules; Haemophilus adhesion and penetration pro-
tein (Hap) [18, 19], high-molecular-weight proteins 1

























































































































Fig. 4 Intracellular invasion of NTHi in the presence of heparin or RGD peptide. BEAS-2B cells were infected for 2 hours with one of the two NTHi
strains (ATCC 19418 or HUSM 0481), E. coli (a negative control), or L. monocytogenes (a positive control). In some experiments, cells were
pretreated with heparin or RGD-peptide. a After killing extracellular bacteria with gentamicin, epithelial cells and bacteria were stained with LIVE/
DEAD®. The percentages of BEAS-2B cells invaded by each type of bacteria are shown. b After killing extracellular bacteria with gentamicin and
lysing the BEAS-2B cells, the bacteria were cultured overnight. The number of colonies was counted and the percentages of CFU after gentamicin
treatment of cells per input CFU were shown. Error bars represent SEM in three independent experiments that gave similar results. *p < 0.05
and **p < 0.01
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influenzae adhesin (Hia) [21], protein-E [22], and
protein-F [23] have all been shown to mediate bacterial
adherence to bronchial epithelial cells. In terms of pene-
tration of NTHi into bronchial epithelial cells, a process
caused by cytoskeletal rearrangement accompanied with
actin and microtubule polymerization allows NTHi to
invade cells. Several mechanisms of direct invasion of H.
influenzae into bronchial epithelial cells have been
reported, including (1) macropinocytosis [24], (2)
platelet-activating factor (PAF) receptor via NTHi phos-
phorylcholine on lipooligosaccharide [25, 26], (3) β-
glucan receptor [27], and (4) α5β1-integrin [11]. These
mechanisms of NTHi penetration are attributed to dir-
ect interactions between NTHi and epithelial cells. How-
ever, mechanisms for indirect invasion of bacteria have
recently been reported; Haemophilus surface fibril (Hsf )
of H. influenzae type b (Hib) was shown to be involved
in the intracellular invasion of Hib via binding to vitro-
nectin [28]. Hsf is a major trimeric autotransporter
adhesin exclusively expressed in encapsulated H.
influenzae strains such as Hib. Hsf binds to the C-
terminal amino acids 352–374 in the heparin-binding
domains (HBDs) of vitronectin. Vitronectin bound to
Hsf increases the adherence and internalization of Hib
into bronchial epithelial cells [28]. Because we used
NTHi, but not Hib, it is unlikely that Hsf is involved in
the intracellular invasion observed in this study. Hia,
which has homology with Hsf in Hib, is a trimeric auto-
transporter found in NTHi. However, Hia is present in
only approximately 25 % of clinical NTHi isolates [29],
and so far, there has been no report to show that Hia is
involved in intracellular invasion of NTHi. Here, we re-
port a novel mechanism of NTHi intracellular invasion
that involves an interaction between NTHi protein-E
and vitronectin. We believe that protein-E, but not Hia,
plays a pivotal role in this NTHi invasion mechanism.
Protein-E is a low molecular-mass (16 kDa) outer mem-
brane lipoprotein and is highly conserved in both NTHi
and encapsulated H. influenzae strains [17, 22]. Protein-E
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HUSM 0481
Fig. 5 Binding of NTHi to immobilized vitronectin in the presence of protein-E peptide. Human plasma vitronectin was bound to glass-bottomed
dishes. NTHi (HUSM 0481) was incubated on the plate-bound vitronectin for 30 minutes, and then the dishes were washed three times. In some
experiments, plate-bound vitronectin was pretreated with protein-E peptide (PE84–108) before incubation with NTHi. BSA was used as a negative
control. NTHi was stained with LIVE/DEAD®, and viable NTHi is stained green. a Representative fluorescent micrographs of NTHi incubated on
plate-bound vitronectin that was untreated or pretreated with PE84–108. White bars represent 10 μm. b The number of attached NTHi per field at
1,000 ×magnification that was pretreated with increasing concentrations of PE84–108. Error bars represent SEM in three independent experiments
that gave similar results. **p < 0.01
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membrane attack complex (MAC)-induced lysis of NTHi
[14, 16, 17]. Protein-E has also been shown to bind immo-
bilized vitronectin [14]. Vitronectin is an important com-
ponent of extracellular matrix and is related to bacterial
serum resistance and adhesion [15]. Binding of vitro-
nectin to vitronectin-binding proteins on bacterial
surface is able to block C5b-7 complex formation and
C9-polymerization, which constitutes MAC, and pro-
tects the bacteria from MAC-induced lysis [14, 15].
Therefore, the binding between vitronectin and
bacteria through vitronectin-binding proteins of bac-
teria, such as protein-E, is essential for this process.
Vitronectin has three HBDs, which interact with vari-
ous bacteria. H. influenzae binds to vitronectin through
the HBDs, and their binding is blocked by heparin [13].
Among the HBDs, the C-terminal HBD-3 of vitronectin
corresponds to a protein-E binding region (amino acids
353–363) [16]. The binding domain of protein-E to
vitronectin includes amino acids 84–108 (PE84–108), and
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Fig. 6 Intracellular invasion of NTHi in the absence or presence of protein-E. BEAS-2B cells were infected for 2 hours with one of the two NTHi
strains (ATCC 19418 or HUSM 0481) with or without pretreatment with PE84–108 peptide. a After killing extracellular bacteria with gentamicin,
epithelial cells and bacteria were stained with LIVE/DEAD®. The percentages of BEAS-2B cells invaded by each NTHi strain are shown. b After
killing extracellular bacteria with gentamicin, cells were lysed and the bacteria were cultured overnight. The number of colonies was counted
and the percentages of CFU after gentamicin treatment of cells per input CFU were shown. Error bars represent SEM in three independent
experiments that gave similar results. *p < 0.05 and **p < 0.01
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NTHi and vitronectin [14]. In agreement with these re-
sults, the present study showed that the PE84–108 peptide
could block adhesion of NTHi to plate-bound vitronec-
tin and that pretreatment with this peptide prevented
NTHi invasion into epithelial cells. Moreover, we dem-
onstrated that BEAS-2B cells abundantly express vitro-
nectin, and that heparin and PE84–108 peptide
pretreatment significantly reduced NTHi intracellular
invasion. These results show that the interaction be-
tween NTHi protein-E and vitronectin plays an import-
ant role in NTHi intracellular invasion (Fig. 7). In this
study, heparin and PE84–108 peptide significantly, but not
completely, diminished the NTHi intracellular invasion.
Thus, other mechanisms may also be involved in this
process. For example, NTHi protein-F has also been re-
ported to bind vitronectin [23]. Protein-F promotes
vitronectin-dependent bacterial adhesion to the cell sur-
face, although the binding strength of protein-F to vitro-
nectin is much weaker than that of protein-E.
Vitronectin has a cell receptor binding site character-
ized by an RGD sequence that interacts with cell surface
integrins [15]. Therefore, an RGD peptide should inhibit
the binding of vitronectin to integrins on bronchial epi-
thelial cells. Streptococcus pneumoniae has been reported
to exploit vitronectin and αvβ3 integrin for its adherence
and intracellular invasion to A549 lung alveolar epithe-
lial cells [30]. However, in our study, RGD peptide did
not block the intracellular invasion of NTHi. Our fluor-
escent study on BEAS-2B cells revealed an intense
expression of vitronectin on the cell surface as well as in
the cytoplasm. Vitronectin may already be bound to
integrins on the epithelial cell surface, which would pre-
vent the intracellular invasion from being affected by the
RGD peptide.
In this study, intracellular NTHi localized in early
endosomes stained with EEA-1, but not in late endo-
somes stained with LAMP-1 or in acidic organelles.
These results were different from those in previous
study, which showed NTHi mainly located in LAMP-1-
positive compartment [4]. This discrepancy may be due
to the difference in the types of epithelial cells used and
in the time points after infection.
Conclusions
The present study demonstrated that the intracellular in-
vasion of NTHi into bronchial epithelial cells is medi-
ated by the interplay between protein-E on NTHi and
vitronectin on bronchial epithelial cells. Our findings
provide novel information about the NTHi-epithelial cell
interaction leading to NTHi entry into these cells. The
protein-E-vitronectin axis may become a novel thera-
peutic target for NTHi infection. Further study is needed
to achieve this goal in clinical practice.
Additional files
Additional file 1: Figure S1. Expression of vitronectin in BEAS-2B cells.
BEAS-2B cells were stained with mouse anti-human vitronectin-antibody
(primary antibody) and then with goat anti-mouse IgG antibody
(secondary antibody, yellow). Nuclei were stained with Hoechst (blue).
Representative fluorescent micrographs at 1,000× magnification are
shown. (A) BEAS-2B cells were stained with the secondary antibody
without the primary antibody. (B) Uninfected BEAS-2B cells. (C) BEAS-2B
cells infected with NTHi. White bars represent 10 μm. (PPTX 4302 kb)
Additional file 2: Figure S2. Intracellular invasion of NTHi in the
presence of increasing dose of heparin. BEAS-2B cells were pretreated
with several concentrations of heparin. These cells were infected for
2 hours with one of the two NTHi strains ((A) ATCC 19418 or (B) HUSM
0481). After killing extracellular bacteria with gentamicin, the BEAS-2B
cells were lysed. The number of colonies was counted and the
percentages of CFU after gentamicin treatment of cells per input CFU
were shown. Error bars represent SEM in three independent experiments
that gave similar results. *p < 0.05. (PPTX 72 kb)
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Fig. 7 A schema of the proposed mechanism by which NTHi
penetrates into bronchial epithelial cell via protein-E and vitronectin.
Vitronectin has three heparin-binding domains (HBDs), which interact
with NTHi. Of those HBDs, the C-terminal HBD-3 corresponds to a
protein-E binding region and interacts with PE84–108. This interaction is
blocked by heparin or PE84–108 peptide. Vitronectin also possesses a cell
receptor binding site characterized by an Arg-Gly-Asp (RGD) sequence,
which interacts with integrins on the bronchial epithelial cell surface.
This protein-E-vitronectin axis seems to play a role in the adherence
and penetration of NTHi into bronchial epithelial cells
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